Grastek
Payments companies reported to CMS as associated with Grastek. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Grastek, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Grastek
These are the largest totals companies reported as associated with Grastek. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Lara Gross | Dallas, TX | Allergy & Immunology | $41,957.91 |
| Michael Blaiss | Roswell, GA | Allergy & Immunology | $28,667.91 |
| Jacqueline Eghrari-Sabet | Vienna, VA | Allergy & Immunology | $22,028.59 |
| Michelle Yasharpour | Beverly Hills, CA | Allergy | $18,044.20 |
| Payal Gupta | Brooklyn, NY | Diagnostic Radiology | $15,600.00 |
| Jonathan Malka | North Miami Beach, FL | Pediatric Allergy/Immunology | $15,436.03 |
| Gary Freed | Canton, MI | Pediatrics | $13,955.12 |
| Nanette Silverberg | Brooklyn, NY | Dermatology | $13,206.98 |
| Alan Rogol | Charlottesville, VA | Pediatrics | $10,520.90 |
| Michal Goldberg | Chicago, IL | Pediatrics | $9,775.14 |
Prescribed Grastek?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.